Acinetobacter is a highly diverse genus ubiquitous in the environment (1,2) and has been considered a significant nosocomial pathogen since 1970 as it can survive in the hospital environment (on both dry and moist surfaces) (3–5). Subsequently, the bacteria are transmitted to patients either from environmental surfaces or from the hands of health care workers that were colonized transiently by these bacteria (6, 7).
The Greek word "akinetos" is the name Acinetobac-ter's origin meaning "unable to move". The term was chosen for the bacteria as they are not motile while displaying a twitching kind of motility (8). The genus belongs to the family Moraxellaceae and comprises Gram-negative, non-motile, oxidase-negative, glucose non-fermenting, strictly aerobic, catalase-positive bacteria (9).
Although there are more than 50 species within the Acinetobacter genus 2, most species are nonpatho-genic. The most common species to cause infections is Acinetobacter baumannii (responsible for 90 % of human infections caused by this genus and responsible for 17% of all nosocomial infections, especially amongst immunocompromised indivi-duals), followed by Acinetobacter calcoaceticus and Acinetobacter lwoffii (10–12).
Human infections caused by Acinetobacter species include community-acquired infections and hospital-acquired infections, especially in critically ill patients with impaired host defenses. These infections include pneumonia, endocarditis, meningitis, skin and wound infections, peritonitis in patients receiving peritoneal dialysis, UTI, and bacteremia (13,14).
There were several reasons that made this genus receive significant attention. First, this genus causes nosocomial infections. Second is the emergence of the multiresistant strains, some of which are Pan-Resis-tant to antibiotics, that suddenly cause an outbreak of infection involving several patients in a clinical unit. Third, some strains have the ability to produce verotoxins (8,15).
Concerning susceptibility between females and males, differences have been reported dealing with vaccination, autoimmune diseases, and infectious diseases (16–19). According to various studies, there is a differential immune response to infectious diseases regarding gender (20–23). The innate immune response of females is typically more substantial on the topic of infection (18).
With respect to the Antibiotic susceptibility pattern of Acinetobacter, it has been documented that susceptibility patterns may vary widely according to geographical regions and even among different units of the same hospital at different time points. This variation makes it necessary to set periodic monitoring for these pathogens to accurately select a therapy (23,24).
Thus the current study aims to study the prevalence of Acinetobacter isolated from clinical samples collected in Al-Kafeel Hospital (2017-2021) and study the antibiotic susceptibility patterns of these isolates, and moreover, to examine the gender-related differe-nces in Acinetobacter infections.
Following the approval of this study from the Department of Clinical Laboratories/ College of Applied Medical Sciences/ Kerbala University, retrospective study designs were conducted from December 2020 to May 2021. During this period, data of the clinical samples received in Al-Kafeel Hospital laboratory from April 2017 to February 2021 were collected. Results that showed the isolation of Acinetobacter spp. with their antibiotic susceptibility testing were obtained. Antibiotic susceptibility testing was done using disc diffusion methods and interpreted using CLSI guidelines (25). Data were analyzed using SPSS 24 software (SPSS Inc., Chicago, Ill., USA).
During the study period, results of 1784 reports for different clinical samples received in the laboratory of Al-Kafeel Hospital were collected. Out of 135 (7.5%), samples were examined by direct methods (gram stain and Acid Fast stain), and 1649 were cultured on MacConkey and Blood agar as requested. After overnight incubation, no growth or growth of nonpathogenic bacteria (i.e., considered as culture-negative cases) was observed in 970 (58.8%), while 111 (6.2%) cases were cultured for the presence of Fungi. A total of 568 cases were reported to have bacterial isolates. Antibiotic susceptibility testing was performed using manual methods for the samples that revealed the presence of pathogenic bacteria in the culture plates (i.e., culture-positive cases). Culture-positive reports were searched for the isolation of Acinetobacter spp. A total of of 52 reports were documented the growth of Acinetobacter spp. (9.2%) from culture-positive cases (Table 1). Acinetobacter species were found to be associated with increased mortality rates (26) due to their ability to infect healthy hosts and their propensity to develop resistance to the broad spectrum Antibiotics (27). Lower prevalence rates were reported by Al-Sehlawi et al., who documented a 6.8% of isolates to be identified as A. baumannii from clinical samples referred to three hospitals in Al-Najaf, Iraq (28). Another study in Kerbala, Iraq, reported higher incidence rates (29). While other studies have accounted for 12.9% (30), 4.8% (23), and 3.36% (24) of Acinetobacter isolates from total infected samples. The observed differences in prevalence rate might be due to variation in the study design, methodology, and study time.
Table 1. Prevalence of infection with Acinetobacter species.
Type of Bacteria | Frequency | Percent |
Acinetobacter | 52 | 9.2 |
Other types of Bacteria | 516 | 90.8 |
Total | 568 | 100 |
Regarding sex, 13 reports for clinical samples were taken from females, and 39 for males, and M/ F ratio was 3/1. There was a significant association between infections with Acinetobacter spp. and sex, as shown in Table 2. Similarly, previous studies documented that Acinetobacter infection was more prevalent in males (32,33). This may be due to male and female differences in immunological responses. In general, stronger innate and adaptive immune responses are reported regarding adult females compared with males.
Sex differences are visible in different species. Exposure to a wide range of stimuli (including bacteria, viruses, parasites, fungi, and vascular trauma) can severely reduce tissue function or lead to its loss in women compared to men (18, 20). Men were less compliant than females to hand-hygiene recommendations which made them more prone to infection (34). Furthermore, men were more likely to be affected by hospital-acquired infections (35, 36), which may be caused by higher hospitalization rates, especially in older age groups.
Table 2. Distribution of infection with Acinetobacter species among gender
Type of Bacteria | Gender | Total | |
Female | Male | ||
Acinetobacter spp. | 13 | 39 | 52 |
Other types of Bacteria | 195 | 321 | 516 |
Total | 208 | 360 | 568 |
Fisher's Exact test (1-sided) | 0.045 |
Concerning the clinical samples, Acinetobacter was isolated from swabs (24) followed by urine samples (8). There was no significant association between the type of sample and Acinetobacter infection, Table 3. In other previous studies, Acinetobacter isolation was predominating in urine (21-27%) and tracheobron-chial secretions (24.8, 48.8%, respectively) (30). Another study reported the predominant isolation of Acinetobacter from blood (36.9%) followed by Pus (22.55), respiratory samples (14.4%), urine (11.7%), and other body fluids (9%). An increase in Acinetobacter occurrence in blood cultures is reported in some hospital departments (24, 31).
Table 3. Association of infection with Acinetobacter and type of clinical sample
Type of Bacteria | Sample type | Total | |||||
Blood | Fluid | Sputum | Swab | Urine | Other samples | ||
Acinetobacter spp. | 5 | 7 | 4 | 24 | 8 | 4 | 52 |
Other types of Bacteria | 84 | 66 | 30 | 198 | 111 | 27 | 516 |
Total | 89 | 73 | 34 | 222 | 119 | 31 | 568 |
P-value | 0.588 |
The frequency of Acinetobacter isolation during the years in the current study revealed a high frequency of isolation in 2020 (53.8%) in comparison to other years, Table 4. This might reflect the increase in the incidence of Acinetobacter infection due to its colonization and survival features (37).
Table 4. Distribution of Acinetobacter infection during 2017-2021
Year | Frequency (Percentage) |
2017 | 3 (5.8) |
2018 | 4 (7.7) |
2019 | 9 (17.3) |
2020 | 28 (53.8) |
2021 | 5 (9.6) |
Total | 49 (94.2) |
Antibiotic Susceptibility Patterns
The susceptibility testing for the isolated Acinetobacter showed high rates of resistance to most antibiotics used. Maximum resistance was recorded for Amoxicillin (100%), followed by 3rd generation cephalosporins, including Cefotaxime (92.3%), Ceftri-axone (91.6%), Ceftazidime (91.3%), and Cefixime (80%). There was growing resistance to carbapenems, Imipenem (42.8%), and Meropenem (62.2%). The lowest resistance rates were found to colistin sulfate (10%) (Table 5).
On the report of the World Health Organization (WHO) published in 2017, there was an urgent need for new antibiotics for 12 pathogens called the ESKAPE (ESKAPE is the acronym for the group of bacteria that include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) (38,39).
Showing an increasing resistance to β-lactams aminoglycoside antibiotics, Acinetobacter has been considered a reservoir of antibiotic-resistant genes in a hospital environment (40). This is confirmed by our results which showed high resistance rates to most antibiotics used. The high resistance rates recorded in the current study are likely to be associated with a wide range of empirical and therapeutic use of antibiotics at hospitals. The employed selective pressure by this results in MDR strains emerging, which in turn may have led to the genes encoding resistance mechanisms (41). Being exposed to certain antibiotics has an advantage to a few resistant organisms in patients already colonized. It makes them become pathogens at the first opportunity (40).
Of the isolates, 42 (80.7%) were MDR isolates (resistant to at least one antibiotic in three or more classes of Antibiotics: Penicillin, Cephalosporin, Aminoglycoside, Fluoroquinolone, Carbapenem. Gup-ta et al. reported that 39.6% of isolates were MDR (24). Higher rates of MDR A. baumannii isolates were reported by Yadav et al. (32). Whereas, in the study by Al-Sehlawi et al., 50 % of the isolates were resistant to major antibiotic classes (28). Apparently, Acinet-obacter tends to develop antibiotic resistance quickly. This might be due to its long-term evolutionary exp-osure to antibiotic-producing organisms in the soil environment (42). Facilitated by complex factors, the spread of resistance included mobile genetic eleme-nts, the misuse of antimicrobial drugs, poor infection control practices, and increased international travel (43).
Table 5. Antibiotic Susceptibility patterns among Acinetobacter spp. isolates
Antibiotic | Antibiotic Class | Number of tested isolates | R (%) | I (%) | S (%) |
---|---|---|---|---|---|
Cefotaxime (30 μg) | 3rd generation Cephalosporins | 39 | 36 (92.3) | - | 3 (7.6) |
Ceftriaxone (30 μg) | 3rd generation Cephalosporins | 48 | 44(91.6) | - | 4(8.3) |
Ceftazidime (30 μg) | 3rd generation Cephalosporins | 46 | 42(91.3) | 2 (4.3) | 2 (4.3) |
Cefixime (10 μg) | 3rd generation Cephalosporins | 21 | 17 (80.9) | 1 (4.7) | 3 (14.2) |
Ciprofloxacin (5 μg) | fluoroquinolones | 52 | 38 (73.0) | 4(7.6) | 10 (19.2) |
Levofloxacin (5 μg) | fluoroquinolones | 51 | 13(25.4) | 18(35.2) | 20(39.2) |
Gentamicin (30 μg) | Aminoglycoside | 51 | 34(66.6) | 1(1.9) | 16(31.3) |
Amikacin (30 μg) | Aminoglycoside | 50 | 37(74) | 2(4) | 11(22) |
Tetracycline (30 μg) | Tetracyclines | 45 | 28(62.2) | 1(2.2) | 16(35.5) |
Imipenem (10 μg) | Carbapenems | 49 | 21(42.8) | 6(12.2) | 22(44.8) |
Meropenem (10 μg) | Carbapenems | 44 | 27 (61.3) | 3(6.8) | 14(31.8) |
Amoxicillin (25 μg) | Penicillin-like antibiotics | 7 | 7(100) | - | - |
Trimethoprim (5 μg) | Others | 37 | 27(72.9) | 5(13.5) | 5(13.5) |
PipracillinTazobactam (110 μg) | Beta lactam -Beta lactamase inhibitors | 27 | 17(62.9) | 4(14.8) | 6(22.2) |
Colistin sulfate (10 μg) | Polymyxin | 10 | 1(10.0) | 2(20.0) | 7(70.0) |
Cefipeme (30 μg) | Cephalosporin antibiotic | 20 | 13(65.0) | 1(5.0) | 6(30.0) |
Acinetobacter is an important opportunistic and emerging pathogen that can lead to severe infections. Spreading easily in the environment, these organisms infect or colonize patients and are able to persist in that environment for several days, a factor that might explain their tendency to cause extended outbreaks.
This study reported a high rate of antibiotic resistance by Acinetobacter isolates, indicating that new antibiotic using standards are better to be set in health centers to prevent the occurrence of bacteria resistance. Thus, to prevent microbial resistance, rational use of antibiotics is essential and new protocols are needed.
Awareness is needed to control the environment, and tasks such as equipment decontamination and strict attention to hand washing should be undertaken to prevent the spread of Acinetobacter in hospitals.
We would like to express our appreciation to Al-Kafeel Hospital, Kerbala, Iraq, for providing the current study's data
Conflicts of Interest
The authors declared no conflict of interest.
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |